The United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of the monoclonal antibody treatment for COVID-19 developed by Regeneron Pharmaceuticals and F. Hoffmann-La Roche AG.
Editorial use only Contact your sales representative for commercial and promotional uses.License this clip
More footage filed by NurPhoto videographers.